Galmed Pharmaceuticals Ltd (GLMD)
0.3641
-0.01
(-2.33%)
USD |
NASDAQ |
Apr 22, 16:00
0.3641
0.00 (0.00%)
Pre-Market: 08:55
Galmed Pharmaceuticals Market Cap: 2.188M for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 2.188M |
| April 19, 2024 | 2.240M |
| April 18, 2024 | 2.276M |
| April 17, 2024 | 2.214M |
| April 16, 2024 | 2.129M |
| April 15, 2024 | 2.260M |
| April 12, 2024 | 2.518M |
| April 11, 2024 | 2.521M |
| April 10, 2024 | 2.404M |
| April 09, 2024 | 2.336M |
| April 08, 2024 | 2.379M |
| April 05, 2024 | 2.038M |
| April 04, 2024 | 1.983M |
| April 03, 2024 | 1.966M |
| April 02, 2024 | 1.944M |
| April 01, 2024 | 1.899M |
| March 28, 2024 | 2.081M |
| March 27, 2024 | 1.984M |
| March 26, 2024 | 1.616M |
| March 25, 2024 | 1.616M |
| March 22, 2024 | 1.569M |
| March 21, 2024 | 1.595M |
| March 20, 2024 | 1.538M |
| March 19, 2024 | 1.580M |
| March 18, 2024 | 1.568M |
| Date | Value |
|---|---|
| March 15, 2024 | 1.539M |
| March 14, 2024 | 1.761M |
| March 13, 2024 | 1.814M |
| March 12, 2024 | 1.816M |
| March 11, 2024 | 1.866M |
| March 08, 2024 | 1.917M |
| March 07, 2024 | 1.917M |
| March 06, 2024 | 1.864M |
| March 05, 2024 | 1.941M |
| March 04, 2024 | 1.970M |
| March 01, 2024 | 2.069M |
| February 29, 2024 | 2.00M |
| February 28, 2024 | 2.019M |
| February 27, 2024 | 1.935M |
| February 26, 2024 | 1.859M |
| February 23, 2024 | 1.829M |
| February 22, 2024 | 1.816M |
| February 21, 2024 | 1.826M |
| February 20, 2024 | 1.916M |
| February 16, 2024 | 1.944M |
| February 15, 2024 | 1.918M |
| February 14, 2024 | 1.859M |
| February 13, 2024 | 1.917M |
| February 12, 2024 | 1.866M |
| February 09, 2024 | 1.816M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.179M
Minimum
Nov 22 2023
176.08M
Maximum
Apr 26 2019
56.23M
Average
65.21M
Median
Nov 09 2020
Market Cap Benchmarks
| Compugen Ltd | 169.21M |
| Pluri Inc | 26.19M |
| BioLine Rx Ltd | 54.13M |
| Can Fite Biofarma Ltd | 9.881M |
| BiomX Inc | 16.30M |
Market Cap Related Metrics
| PS Ratio | 0.5769 |
| Price to Book Value | 0.1577 |
| Price | 0.3641 |
| Earnings Yield | -895.4% |